Search research articles
Contact Us
Filters
Showing results (151-160 of 7,133) with videos related to
Page
of 714
Sort By:
British Medical Journal
|
August 27, 2010
LOCAL ANAESTHESIA IN GYNAECOLOGY
A A Davis
Journal of the National Medical Association
|
October 5, 2010
Some Facts Relative to Negro Mortality in the United States
W A Davis
Journal of the Royal Society of Medicine
|
October 5, 2010
Homo sapiens - a species too successful
J A Davis
Journal of the Royal Society of Medicine
|
October 5, 2010
Medical scientism
J A Davis
Evidence-Based Medicine
|
May 4, 2010
Cost-effectiveness analysis: Compared with glyburide, sitagliptin associated with incremental cost-effectiveness ratio of $169,572 per QALY and exenatide with $278,935 per QALY as second-line treatment in adult diabetics in the USA
Wendy A Davis
Journal of the Royal Society of Medicine
|
December 1, 1978
Strengthening the primary care of children
J A Davis
Medical Times
|
March 1, 1980
How I treat groin eruptions
S A Davis
Nursing Times
|
March 6, 1982
Working together. Staff at a psychogeriatric day unit found a closer working relationship with ambulancemen a valuable asset
E A Davis
Journal of Emergency Nursing
|
January 1, 1980
EDNA membership survey
N A Davis
The Australian Nurses' Journal. Royal Australian Nursing Federation
|
June 1, 1981
Alternative birth centre: geography or a philosophy?
J A Davis
Page
of 714
Search research articles
Search
Showing results (151-160 of 7,133) with videos related to
Sort By:
Page
of 714
British Medical Journal
|
August 27, 2010
LOCAL ANAESTHESIA IN GYNAECOLOGY
A A Davis
Journal of the National Medical Association
|
October 5, 2010
Some Facts Relative to Negro Mortality in the United States
W A Davis
Journal of the Royal Society of Medicine
|
October 5, 2010
Homo sapiens - a species too successful
J A Davis
Journal of the Royal Society of Medicine
|
October 5, 2010
Medical scientism
J A Davis
Evidence-Based Medicine
|
May 4, 2010
Cost-effectiveness analysis: Compared with glyburide, sitagliptin associated with incremental cost-effectiveness ratio of $169,572 per QALY and exenatide with $278,935 per QALY as second-line treatment in adult diabetics in the USA
Wendy A Davis
Journal of the Royal Society of Medicine
|
December 1, 1978
Strengthening the primary care of children
J A Davis
Medical Times
|
March 1, 1980
How I treat groin eruptions
S A Davis
Nursing Times
|
March 6, 1982
Working together. Staff at a psychogeriatric day unit found a closer working relationship with ambulancemen a valuable asset
E A Davis
Journal of Emergency Nursing
|
January 1, 1980
EDNA membership survey
N A Davis
The Australian Nurses' Journal. Royal Australian Nursing Federation
|
June 1, 1981
Alternative birth centre: geography or a philosophy?
J A Davis
Page
of 714